Takeda Pharmaceutical, Japan's largest pharmaceutical company. Submitting an approval for the use of the COVID-19 vaccine Of moderna to the regulators of Japan This will make it the third vaccine to be used in a nationwide vaccination program that started last month.
Takeda is in charge slotxo of approving the use of Moderna vaccine in Japan. And is an importer of the vaccine approximately 50 million doses, Takeda previously predicted that Modena vaccine may be approved in May.
Takeda plans to begin distributing Moderna vaccine in the first half of this year. Nova Wax is expected to begin by the end of 2021.
Masayuki Imagawa, Takeda's head of vaccine business in Japan Stated in the statement that “Takeda is committed to delivering the vaccine against COVID-19. Of moderna in Japan as quickly as possible "
Takeda is also overseeing the Novavax vaccine approval process and is responsible for producing about 250 million doses of the vaccine in the country, with the vaccine going into clinical testing in Japan. At the end of February in the past